BioNTech (BNTX) reports 2025 financial results and a €17.2B cash position. Read about the upcoming oncology readouts and the co-founders' new ...

Ripple expands institutional crypto trading by adding Coinbase Derivatives futures to Ripple Prime, boosting access to regulated BTC and ETH contracts.

Strategy Inc boosts bitcoin holdings to 720,737 BTC after a $204m buy, reinforcing its lead as the largest corporate bitcoin ...

Commonwealth Bank of Australia (ASX:CBA) has referred two mortgage brokers and a network of accountants to the NSW Police following the discovery of a sophisticated loan fraud scheme potentially worth ...

ImmunityBio (NASDAQ:IBRX) announced positive results Tuesday from its ANKTIVA® clinical program, signaling a potential paradigm shift in the treatment of advanced non-small cell lung cancer (NSCLC) ...

Cal-Maine Foods (NASDAQ:CALM), the largest producer and distributor of fresh shell eggs in the United States, finalized a significant expansion of its Midwest operations on Monday. The company ...

ImmunityBio (NASDAQ:IBRX) announced Wednesday that the Saudi Food and Drug Authority (SFDA) has approved ANKTIVA® (nogapendekin alfa inbakicept) for the treatment of non-muscle invasive bladder cancer ...

The U.S. Consumer Price Index (CPI) rose at an annual rate of 2.7% in December 2025, matching the previous month’s pace and signaling that the long-awaited "last mile" to the Federal Reserve’s 2% ...

The completion of Australia's largest battery project has faced a significant setback, with developer Akaysha Energy confirming that the Waratah Super Battery will not be fully operational until the ...

Woolworths (ASX:WOW) has signalled a robust recovery in the first half of FY26, posting a 16.4% jump in net profit to $859 million as it narrows the competitive gap with rival Coles (ASX:COL). Despite ...

Comprehensive cross-platform coverage of the U.S. market close on Bloomberg Television, Bloomberg Radio, and YouTube with Romaine Bostick, Kristine Aquino, Carol Massar and Tim Stenovec.

Recursion (NASDAQ:RXRX) reported fourth-quarter 2025 revenue of $35.5 million on Wednesday, significantly exceeding analyst estimates of $24.6 million. The performance was driven by the timing of ...